Nitric oxide synthase activity in hyperthyroid and hypothyroid rats.
OBJECTIVE
Thyroid disorders are accompanied by important changes in haemodynamic and cardiac functions and renal sodium handling. Since nitric oxide (NO) plays a crucial role in regulating vascular tone and renal sodium excretion, the present paper was designed to determine whether changes in the activity of NO synthase (NOS) participate in the cardiovascular and renal manifestations of thyroid disorders.


METHODS
We measured NOS activity in the heart (left and right ventricles), vessels (aorta and cava) and kidney (cortex and medulla) of euthyroid, hyperthyroid and hypothyroid rats after 6 weeks of treatment. NOS activity was determined by measuring the conversion of L-[(3)H]-arginine to L-[(3)H]-citruline.


RESULTS
NOS activity was higher in all tissues from hyperthyroid rats when compared with controls, except in the right ventricle. In the hypothyroid group, NOS activity showed a more heterogeneous pattern, with significant increases in both ventricles but significant reduction in the aorta, while in the vena cava, renal cortex and medulla the enzyme activity also tended to be higher, but significance was not reached.


CONCLUSIONS
These data indicated that NOS activity was upregulated in tissues primarily related to blood pressure control in hyperthyroid rats, suggesting that an increased NO production may contribute to the hyperdynamic circulation in hyperthyroidism and may have a protective homeostatic effect in the target organs of the hypertension that accompanies this endocrine disease. The aortic and renal findings in hypothyroid rats suggested a possible role for NOS in the increased peripheral resistance and the normal pressure-diuresis-natriuresis response of these hypotensive animals, although hypothyroidism produced a heterogeneous tissue response in NOS activity.
Quesada
Andrés
A
Departamento de Fisiología de la Facultad de Medicina de Granada, Granada, Spain.
Sainz
Juan
J
Wangensteen
Rosemary
R
Rodriguez-Gomez
Isabel
I
Vargas
Félix
F
Osuna
Antonio
A
D000818:Animals; D001011:Aorta / Q000201:enzymology; D001120:Arginine / Q000493:pharmacokinetics; D001921:Brain / Q000201:enzymology; D002956:Citrulline / Q000493:pharmacokinetics; D006980:Hyperthyroidism / Q000201:enzymology*; D007037:Hypothyroidism / Q000201:enzymology*; D007668:Kidney / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014316:Tritium; D014684:Venae Cavae / Q000201:enzymology
D014316:Tritium; D002956:Citrulline; D001120:Arginine; D019001:Nitric Oxide Synthase